Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

21. Newborn hearing screening programme (NHSP) operational guidance

Newborn hearing screening programme (NHSP) operational guidance Newborn hearing screening programme (NHSP) operational guidance - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Newborn hearing screening programme (NHSP) operational guidance This guidance supports healthcare professionals and stakeholders delivering and managing newborn hearing screening programmes in England. Published 1 November 2016 (...) Last updated 16 July 2019 — From: Documents HTML HTML HTML HTML HTML HTML HTML HTML HTML HTML HTML https://www.gov.uk/government/publications/newborn-hearing-screening-equipment-log-sheets If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. MS Word Document , 23.9KB This file may not be suitable for users

2019 Public Health England

22. Interventions Used to Screen for Clostridioides Difficile: Clinical Effectiveness and Guidelines

Interventions Used to Screen for Clostridioides Difficile: Clinical Effectiveness and Guidelines Interventions Used to Screen for Clostridioides Difficile: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Interventions Used to Screen for Clostridioides Difficile: Clinical Effectiveness and Guidelines Interventions Used to Screen for Clostridioides Difficile: Clinical Effectiveness and Guidelines Last updated: July 29, 2019 Project Number: RA1048-000 Product Line (...) : Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical effectiveness of interventions used to screen individuals for Clostridioides difficile? What are the evidence-based guidelines regarding interventions used to screen individuals for Clostridioides difficile? Key Message Three evidence-based guidelines were identified regarding interventions used to screen individuals for Clostridioides difficile. Files Rapid Response Reference List Published

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

23. The Impact of Adverse Childhood Experiences on the Utilization of Cervical Cancer Screening

The Impact of Adverse Childhood Experiences on the Utilization of Cervical Cancer Screening "The Impact of Adverse Childhood Experiences on the Utilization of Cerv" by Jennifer Mings < > > > > > Title Author Date of Graduation Summer 8-10-2019 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies Rights . Abstract Abstract Background: Adverse childhood experiences (ACEs) are prevalent for many women, and have been proven to lead to an increase in chronic (...) diseases including cancer. While the mechanism behind this is not completely understood, the literature suggests that it may be partially due to decreased utilization of cancer screening. Due to the widespread nature of cervical cancer, this literature review seeks to investigate the relationship between ACEs and cervical cancer screening. Methods: An exhaustive literature search of MEDLINE-PubMed, Web of Science, Public Health Database, and PyschINFO was performed. The keywords used in the search

2019 Pacific University EBM Capstone Project

24. Comparison of FMF and NICE Algorithms in Early Preeclampsia Screening at 11-13 Weeks Gestation

Comparison of FMF and NICE Algorithms in Early Preeclampsia Screening at 11-13 Weeks Gestation "Comparison of FMF and NICE Algorithms in Early Preeclampsia Screening " by Lauren Voelker and Mergitu Gemeda < > > > > > Title Author Date of Graduation Summer 8-10-2019 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies Rights . Abstract Background:Approximately 3% of pregnant women develop preeclampsia at some time during their pregnancy. Preeclampsia (...) is a common cause of maternal and fetal morbidity and mortality worldwide. Currently there are 3 assessment tools for preeclampsia: the National Institute for Health and Care Excellence (NICE) guidelines, the American College of Obstetricians and Gynecologist (ACOG) and the Fetal Medicine Foundation (FMF) algorithm. Both NICE and ACOG guidelines use maternal demographics and medical history as a screening tool. The more recent approach, FMF uses Bayes theorem utilizes biophysical and biochemical markers

2019 Pacific University EBM Capstone Project

25. Screening for Asymptomatic Bacteriuria in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. (PubMed)

Screening for Asymptomatic Bacteriuria in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Screening for asymptomatic bacteriuria can identify patients for whom treatment might be beneficial for preventing symptomatic infection and other health outcomes.To systematically review benefits and harms of asymptomatic bacteriuria screening and treatment in adults, including during pregnancy, to inform the US Preventive Services Task Force.MEDLINE (...) , PubMed (publisher-supplied records), and Cochrane Collaboration Central Registry of Controlled Trials; surveillance through May 24, 2019.Randomized clinical trials (RCTs) and observational studies on benefits and harms of screening for asymptomatic bacteriuria; RCTs on benefits and harms of asymptomatic bacteriuria treatment. Eligible populations included unselected, asymptomatic individuals without known urinary tract conditions.Independent critical appraisal and data abstraction by 2 reviewers

2019 JAMA

26. Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement. (PubMed)

Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement. Among the general adult population, women (across all ages) have the highest prevalence of asymptomatic bacteriuria, although rates increase with age among both men and women. Asymptomatic bacteriuria is present in an estimated 1% to 6% of premenopausal women and an estimated 2% to 10% of pregnant women and is associated with pyelonephritis, one of the most common nonobstetric reasons (...) for hospitalization in pregnant women. Among pregnant persons, pyelonephritis is associated with perinatal complications including septicemia, respiratory distress, low birth weight, and spontaneous preterm birth.To update its 2008 recommendation, the USPSTF commissioned a review of the evidence on potential benefits and harms of screening for and treatment of asymptomatic bacteriuria in adults, including pregnant persons.This recommendation applies to community-dwelling adults 18 years and older and pregnant

2019 JAMA

27. Fetal anomaly screening laboratory handbook: Down’s, Edwards’ and Patau’s syndromes

Fetal anomaly screening laboratory handbook: Down’s, Edwards’ and Patau’s syndromes Fetal anomaly screening laboratory handbook: Down’s, Edwards’ and Patau’s syndromes - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search The United Kingdom is leaving the European Union on 31 October 2019. Guidance Fetal anomaly screening laboratory handbook: Down’s, Edwards’ and Patau’s syndromes This document sets out screening (...) laboratory guidelines and recommendations for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome. Published 1 January 2015 Last updated 13 September 2019 — From: Documents Ref: PHE publications gateway number: GW-691 HTML format This file may not be suitable for users of assistive technology. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what

2019 Public Health England

28. Syphilis Screening in Pregnancy

Syphilis Screening in Pregnancy September 2019 INTERIM GUIDELINE ON SYPHILIS SCREENING IN PREGNANCY In April 2019, the first case of congenital syphilis in British Columbia since 2013 was reported. A second case of congenital syphilis was reported in May 2019 in a stillborn delivered in January 2019. Current and past practice in BC has included screening for syphilis as part of routine care in the first trimester; historically subsequent syphilis screening has not been routinely recommended (...) unless there was concern for syphilis risk during pregnancy. There have been ongoing discussions between the BC Centre for Disease Control’s Sexually Transmitted Infections (BCCDC STI) team and expert partners and stakeholders about the best way to approach syphilis screening in pregnancy. Recent epidemiologic syphilis trends seen in BC – including increased overall rates, increased rates in females of reproductive age, along with an increasing number of infectious syphilis cases among males who

2019 British Columbia Perinatal Health Program

29. School dental screening programmes for oral health. (PubMed)

School dental screening programmes for oral health. School dental screening refers to visual inspection of children's oral cavity in a school setting followed by making parents aware of their child's current oral health status and treatment needs. Screening at school intends to identify children at an earlier stage than symptomatic disease presentation, hence prompting preventive and therapeutic oral health care for the children. This review evaluates the effectiveness of school dental (...) screening in improving oral health status. It is an update of the original review, which was first published in December 2017.To assess the effectiveness of school dental screening programmes on overall oral health status and use of dental services.Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 4 March 2019), the Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Register of Studies, to 4 March 2019), MEDLINE

2019 Cochrane

30. Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. (PubMed)

Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Pancreatic adenocarcinoma is the third most common cause of cancer death among men and women in the United States.To systematically review benefits and harms of screening for pancreatic adenocarcinoma to inform the US Preventive Services Task Force.MEDLINE, PubMed, and the Cochrane Collaboration Registry of Controlled Trials, from January 2002 through April 27, 2018 (...) ; surveillance through March 22, 2019.Studies of adults with or without risk factors for pancreatic adenocarcinoma (eg, family history of pancreatic cancer, personal history of new-onset diabetes) undergoing imaging-based screening; studies of treatment for adults with screen-detected or asymptomatic pancreatic adenocarcinoma. Included study designs were randomized clinical trials, nonrandomized controlled intervention studies, diagnostic accuracy studies with a reference standard, cohort studies, and case

2019 JAMA

31. Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. (PubMed)

Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. Pancreatic cancer is an uncommon cancer with an age-adjusted annual incidence of 12.9 cases per 100 000 person-years. However, the death rate is 11.0 deaths per 100 000 person-years because the prognosis of pancreatic cancer is poor. Although its incidence is low, pancreatic cancer is the third most common cause of cancer death in the United States. Because of the increasing incidence (...) of pancreatic cancer, along with improvements in early detection and treatment of other types of cancer, it is estimated that pancreatic cancer may soon become the second-leading cause of cancer death in the United States.To update the 2004 US Preventive Services Task Force (USPSTF) recommendation on screening for pancreatic cancer.The USPSTF reviewed the evidence on the benefits and harms of screening for pancreatic cancer, the diagnostic accuracy of screening tests for pancreatic cancer, and the benefits

2019 JAMA

32. Hepatitis B Virus Infection in Pregnant Women: Screening

Hepatitis B Virus Infection in Pregnant Women: Screening Final Recommendation Statement: Hepatitis B Virus Infection in Pregnant Women: Screening - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 5/9/2019 1:01:08 PM You are here: Final Recommendation Statement : Final Recommendation Statement Final Recommendation Statement Hepatitis B Virus Infection in Pregnant Women: Screening Recommendations made by the USPSTF are independent (...) of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. Recommendation Summary Recommendation Summary Population Recommendation Grade Pregnant women The USPSTF recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit To read the recommendation statement in JAMA , select . To read the evidence summary in JAMA , select . Table

2019 U.S. Preventive Services Task Force

33. Pancreatic Cancer: Screening

Pancreatic Cancer: Screening Final Recommendation Statement: Pancreatic Cancer: Screening - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 5/9/2019 1:01:08 PM You are here: Final Recommendation Statement : Final Recommendation Statement Final Recommendation Statement Pancreatic Cancer: Screening Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency (...) for Healthcare Research and Quality or the U.S. Department of Health and Human Services. Recommendation Summary Population Recommendation Grade Adults The USPSTF recommends against screening for pancreatic cancer in asymptomatic adults. To read the recommendation statement in JAMA , select . To read the evidence summary in JAMA , select . Table of Contents Preface The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients

2019 U.S. Preventive Services Task Force

34. Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders

Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 41, Issue 7, Pages 1035–1049 No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders x Sebastian R. Hobson , MD MPH PhD Toronto, ON x John C. Kingdom , MD Toronto, ON x Ally Murji , MD (...) accreta spectrum (PAS) disorders are a potentially life-threatening complication of pregnancy that demand coordinated interdisciplinary care to achieve safer outcomes. The rising incidence of this disease is due to a growing number of uterine surgical procedures, including the rising incidence of pregnancy following Caesarean section. Objective To provide current evidence-based guidelines on the optimal methods used to effectively screen, diagnose, and manage PAS disorders. Methods Members

2019 Society of Obstetricians and Gynaecologists of Canada

35. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding

Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding - ACOG Menu ▼ Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding Page Navigation ▼ Number 785 Committee on Adolescent Health Care This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care (...) in collaboration with committee members Oluyemisi Adeyemi-Fowode, MD and Judith Simms-Cendan, MD. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding ABSTRACT : Heavy menstrual bleeding is defined as excessive menstrual blood loss that interferes with a woman's physical, social, emotional, or material quality of life. If obstetrician–gynecologists suspect that a patient has a bleeding disorder, they should work in coordination with a hematologist for laboratory

2019 American College of Obstetricians and Gynecologists

36. Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging

Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging Federal legislation proposes requiring that screening mammography reports to practitioners and women incorporate breast density information and that women with dense breasts discuss supplemental imaging with their practitioner given their increased risk of interval breast cancer. Instead of discussing supplemental imaging with all women with dense breasts, it may (...) be more efficient to identify women at high risk of advanced breast cancer who may benefit most from supplemental imaging.To identify women at high risk of advanced breast cancer to target woman-practitioner discussions about the need for supplemental imaging.This prospective cohort study assessed 638 856 women aged 40 to 74 years who had 1 693 163 screening digital mammograms taken at Breast Cancer Surveillance Consortium (BCSC) imaging facilities from January 3, 2005, to December 31, 2014. Data

2019 EvidenceUpdates

37. Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine)

Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine) Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine) - INAHTA Brief

2019 Haute Autorite de sante

38. What is the pathophysiology behind hepatic osteopenia/osteoporosis and who should be screened for it?

What is the pathophysiology behind hepatic osteopenia/osteoporosis and who should be screened for it? Chiefs’ Inquiry Corner August 5th, 2019 – Clinical Correlations Search Chiefs’ Inquiry Corner August 5th, 2019 August 5, 2019 2 min read Patients with chronic liver disease are nearly three times more likely to develop osteoporosis than matched controls. In contrast to patients with post-menopausal osteoporosis, in whom increased osteoclast activity depletes bone density, the mechanism (...) in patients with liver disease is thought to be driven by decreased osteoblast activity. Patients with liver disease see decreases in osteoblastogenesis stimulating factors such as IGF-1 and vitamin K and increases in serum bilirubin, which directly inhibits osteoblastogenesis. It is recommended to screen the following female and male patients for hepatic osteopenia: All patients with cirrhosis All patients with chronic cholestasis (bilirubin >3mg/dL for 6 months) All potential liver transplant candidates

2019 Clinical Correlations

39. Choosing Wisely Canada recommendation - Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in th

Choosing Wisely Canada recommendation - Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in th Don’t do imaging for lower-back pain unless red flags are present. Red flags include, but are not limited to, severe or progressive neurological deficits or when serious underlying conditions such as osteomyelitis are suspected. Imaging (...) all cases are viral. Though cases of bacterial sinusitis can benefit from antibiotics, evidence of such cases does not typically surface until after at least seven days of illness. Not only are antibiotics rarely indicated for upper respiratory illnesses, but some patients experience adverse effects from such medications. Don’t order screening chest X-rays and ECGs for asymptomatic or low risk outpatients. There is little evidence that detection of coronary artery stenosis in asymptomatic patients

2019 CPG Infobase

40. External Validation of Two Models to Predict Delirium in Critically Ill Adults Using Either the Confusion Assessment Method-ICU or the Intensive Care Delirium Screening Checklist for Delirium Assessment

External Validation of Two Models to Predict Delirium in Critically Ill Adults Using Either the Confusion Assessment Method-ICU or the Intensive Care Delirium Screening Checklist for Delirium Assessment To externally validate two delirium prediction models (early prediction model for ICU delirium and recalibrated prediction model for ICU delirium) using either the Confusion Assessment Method-ICU or the Intensive Care Delirium Screening Checklist for delirium assessment.Prospective (...) Care Delirium Screening Checklist. Discrimination was determined using the area under the receiver operating characteristic curve. The predictive performance was determined for the Confusion Assessment Method-ICU and Intensive Care Delirium Screening Checklist cohort, and compared with both prediction models' original reported performance. A total of 1,286 Confusion Assessment Method-ICU-assessed patients and 892 Intensive Care Delirium Screening Checklist-assessed patients were included. Compared

2019 EvidenceUpdates